KRAZATI
Live / Registered — Registered (as of 04 Apr 2023)
What this means for you
Registered since 04 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90603915
- Registration number
- 7019779
- Mark type
- Stylized text
- Filed
- 25 Mar 2021
- Published for opposition
- 22 Feb 2022
- Registered
- 04 Apr 2023
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
- Class 042 — Scientific and technological services: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Owner
- Mirati Therapeutics, Inc., San Diego, CA, US
- Mirati Therapeutics, Inc., San Diego, CA, US
- Mirati Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 25 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 28 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jan 2023 — USE AMENDMENT FILED
- 30 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 19 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Oct 2022 — SOU EXTENSION 1 GRANTED
- 17 Oct 2022 — SOU EXTENSION 1 FILED
- 17 Oct 2022 — SOU TEAS EXTENSION RECEIVED